Cardiopulmonary bypass (CPB) stands as a crucial medical intervention utilized during cardiac surgeries, temporarily assuming the vital functions of the heart and lungs. This intricate procedure involves rerouting the patient's blood away from the heart and lungs, employing a heart-lung machine to take charge of oxygenation and blood circulation throughout the body. Acting as a surrogate for natural physiological processes, the machine effectively removes carbon dioxide and adds oxygen to the blood. By inducing a state of motionlessness and bloodlessness in the heart, CPB enables surgeons to conduct intricate cardiac procedures that would otherwise be challenging or impractical. While integral to various cardiac interventions, the application of cardiopulmonary bypass comes with inherent risks. Ongoing research is dedicated to refining CPB techniques to minimize potential complications, ensuring improved patient outcomes. The evolution of this technology has significantly propelled the field of cardiac surgery, revolutionizing the landscape of life-saving interventions and enhancing the overall success of complex cardiac procedures.
Title : Investigating the long-term follow up of atrial septal device closures in wales and england: A comparative analysis with major adverse cardiovascular Events (MACE)
Meera Gopinath, Cardiff University Medical school, United Kingdom
Title : An adult case of polysplenia syndrome associated with sinus node dysfunction
Apoorva Tripathi, Oxford University Hospitals, United Kingdom
Title : A unique cell-driven phenomenon in the heart and the promising future of the innovative translational tools to manage cardiac self-renewal and regeneration
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Yasser’s criterion of inferior ST-segment discrepancy deviations in AF with aberrancy and Sgarbosa criteria - a new cardiovascular discovery and management - a case report
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt